APA (7th ed.) Citation

Cherkasova, Z. R., Tsurkan, S. A., Prostyakova, A. I., Boroda, A. M., Rozhkov, A. A., Pirogova, Y. N., . . . Sekacheva, M. I. (2023). Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen. QUASAR, LLC.

Chicago Style (17th ed.) Citation

Cherkasova, Zh. R., S. A. Tsurkan, A. I. Prostyakova, A. M. Boroda, A. A. Rozhkov, Yu. N. Pirogova, N. M. Nikitina, and M. I. Sekacheva. Potential Clinical Application of the Cancer Antigen CA‑62 for Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia at the Elevated Prostate‑specific Antigen. QUASAR, LLC, 2023.

MLA (9th ed.) Citation

Cherkasova, Zh. R., et al. Potential Clinical Application of the Cancer Antigen CA‑62 for Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia at the Elevated Prostate‑specific Antigen. QUASAR, LLC, 2023.